Euan A. Stronach

8.4k total citations
37 papers, 1.6k citations indexed

About

Euan A. Stronach is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Euan A. Stronach has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Reproductive Medicine and 11 papers in Cancer Research. Recurrent topics in Euan A. Stronach's work include Ovarian cancer diagnosis and treatment (14 papers), Renal cell carcinoma treatment (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Euan A. Stronach is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Renal cell carcinoma treatment (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Euan A. Stronach collaborates with scholars based in United Kingdom, United States and Germany. Euan A. Stronach's co-authors include Hani Gabra, Robert Brown, Gordon B. Mills, Roshan Agarwal, Harpreet Wasan, Nona Rama, John F. Smyth, Grant C. Sellar, Eric P. Miller and Genevieve J. Rabiasz and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Euan A. Stronach

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Euan A. Stronach United Kingdom	22	1.1k	463	437	252	157	37	1.6k
Youji Feng China	29	1.2k 1.1×	496 1.1×	506 1.2×	388 1.5×	108 0.7×	56	1.9k
Yoke-Eng Chiew Australia	8	782 0.7×	559 1.2×	502 1.1×	599 2.4×	172 1.1×	9	1.5k
Ashish Juvekar United States	11	804 0.7×	468 1.0×	316 0.7×	67 0.3×	131 0.8×	22	1.3k
Fabian Coscia Germany	17	1.1k 1.0×	332 0.7×	266 0.6×	98 0.4×	127 0.8×	29	1.7k
Kang Jin Jeong United States	23	1.3k 1.2×	492 1.1×	481 1.1×	73 0.3×	145 0.9×	32	1.7k
Andrea H. Bild United States	22	1.2k 1.0×	704 1.5×	504 1.2×	64 0.3×	278 1.8×	56	1.9k
Dawn R. Cochrane United States	24	1.6k 1.5×	664 1.4×	1.3k 3.0×	345 1.4×	334 2.1×	44	2.7k
Yasir H. Ibrahim United States	12	1.1k 1.0×	828 1.8×	249 0.6×	69 0.3×	305 1.9×	22	1.6k
Doris R. Siwak United States	18	1.2k 1.0×	462 1.0×	224 0.5×	62 0.2×	213 1.4×	27	1.7k
Mika K. Derynck United States	15	648 0.6×	553 1.2×	281 0.6×	129 0.5×	308 2.0×	34	1.5k

Countries citing papers authored by Euan A. Stronach

Since Specialization

Citations

This map shows the geographic impact of Euan A. Stronach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Euan A. Stronach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Euan A. Stronach more than expected).

Fields of papers citing papers by Euan A. Stronach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Euan A. Stronach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Euan A. Stronach. The network helps show where Euan A. Stronach may publish in the future.

Co-authorship network of co-authors of Euan A. Stronach

This figure shows the co-authorship network connecting the top 25 collaborators of Euan A. Stronach. A scholar is included among the top collaborators of Euan A. Stronach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Euan A. Stronach. Euan A. Stronach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cunnea, Paula, Edward Curry, Elizabeth L. Christie, et al.. (2023). Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes. Cell Reports Medicine. 4(6). 101055–101055. 19 indexed citations

Najgebauer, Hanna, Mi Yang, Hayley E. Francies, et al.. (2020). CELLector: Genomics-Guided Selection of Cancer In Vitro Models. Cell Systems. 10(5). 424–432.e6. 27 indexed citations

Gonçalves, Emanuel, Fiona M. Behan, Sandra Louzada, et al.. (2019). Structural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects. Genome biology. 20(1). 27–27. 32 indexed citations

Blagden, Sarah P., Anne Hamilton, Linda Mileshkin, et al.. (2018). Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer. Clinical Cancer Research. 25(5). 1472–1478. 50 indexed citations

Stronach, Euan A., James Paul, Kirsten M. Timms, et al.. (2018). Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy. Molecular Cancer Research. 16(7). 1103–1111. 81 indexed citations

Matassa, Danilo Swann, Maria Rosaria Amoroso, Haonan Lu, et al.. (2016). Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death and Differentiation. 23(9). 1542–1554. 143 indexed citations

Lanchbury, Jerry S., Kirsten M. Timms, Euan A. Stronach, et al.. (2016). 3-biomarker HRD score versus individual biomarker (LOH, TAI, LST) scores in platinum treated serous ovarian cancer (SOC). Annals of Oncology. 27. vi34–vi34. 3 indexed citations

Mills, Gordon B., Kirsten M. Timms, J. Reid, et al.. (2016). Homologous recombination deficiency score shows superior association with outcome compared with its individual score components in platinum-treated serous ovarian cancer. Gynecologic Oncology. 141. 2–3. 19 indexed citations

Stronach, Euan A., et al.. (2015). Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy. Frontiers in Oncology. 5. 240–240. 28 indexed citations

10.

Cunnea, Paula & Euan A. Stronach. (2014). Modeling Platinum Sensitive and Resistant High-Grade Serous Ovarian Cancer: Development and Applications of Experimental Systems. Frontiers in Oncology. 4. 81–81. 13 indexed citations

11.

Chapman‐Rothe, Nadine, Edward Curry, C Zeller, et al.. (2012). Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells. Oncogene. 32(38). 4586–4592. 65 indexed citations

12.

Perumal, Meg, Euan A. Stronach, Hani Gabra, & Eric O. Aboagye. (2012). Evaluation of 2-Deoxy-2-[18F]Fluoro-D-glucose- and 3′-Deoxy-3′-[18F]Fluorothymidine–Positron Emission Tomography as Biomarkers of Therapy Response in Platinum-Resistant Ovarian Cancer. Molecular Imaging and Biology. 14(6). 753–761. 20 indexed citations

13.

Stronach, Euan A., Nona Rama, Christoph Datler, et al.. (2011). HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer. Cancer Research. 71(13). 4412–4422. 148 indexed citations

14.

Dai, Wei, Jens M. Teodoridis, Constanze Zeller, et al.. (2011). Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival. Clinical Cancer Research. 17(12). 4052–4062. 78 indexed citations

15.

Stronach, Euan A., Michelle Chen, Roshan Agarwal, et al.. (2011). DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance. Neoplasia. 13(11). 1069–IN35. 111 indexed citations

16.

Saleem, Azeem, Roshan Agarwal, Sarah P. Blagden, et al.. (2011). Pharmacokinetic (PK)/pharmacodynamic (PD) analysis of escalating repeat doses of the AKT inhibitor GSK2141795 (GSK795) in patients (pts) with ovarian cancer.. Journal of Clinical Oncology. 29(15_suppl). 5064–5064. 13 indexed citations

17.

Stronach, Euan A., et al.. (2009). Microarray coupled to quantitative RT–PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene. 28(19). 2051–2063. 54 indexed citations

18.

Zucknick, Manuela, Sylvia Richardson, & Euan A. Stronach. (2008). Comparing the Characteristics of Gene Expression Profiles Derived by Univariate and Multivariate Classification Methods. Statistical Applications in Genetics and Molecular Biology. 7(1). Article7–Article7. 47 indexed citations

19.

Stronach, Euan A., Nona Rama, & Hani Gabra. (2008). Identification of functional modulators of platinum resistance using isogenically matched ovarian cancer cell line models.. Cancer Research. 68. 699–699. 2 indexed citations

20.

Stronach, Euan A., Grant C. Sellar, Cherie Blenkiron, et al.. (2003). Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.. PubMed. 63(24). 8648–55. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact